Maternal Abdominal Morphology Assessment
NCT06784674
Summary
Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes. The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.
Eligibility
Inclusion Criteria: * Pregnant women, with a singleton gestation * Age 18 - 54 years at screening * Gestational age \< 14 weeks * Willing to commit to 1 year postpartum follow up * Planning to remain in geographical vicinity of Austin for 1 year after delivery Exclusion Criteria: * Presence of any mechanically or magnetically activated implants * Claustrophobia * Other contraindication for MRI * BMI ≥ 38.0 or maximum width less than 48 cm (necessary to fit within the MRI field of view)
Conditions4
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06784674